Physician profile
Ryan V Nowlin
NPI 1427058999
$2,687.78
in general payments reported to CMS, 2019-2025
7 companies · $545 in 2025
The $545 reported for 2025 was more than what 82% of Orthodontics and Dentofacial Orthopedics providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $461 · 2020: $160 · 2021: $250 · 2022: $311 · 2023: $652 · 2024: $307 · 2025: $545.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,425 · Consulting Fee: $80.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,424.71 |
| Consulting Fee | $80.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $1,998.70 | 2019-2025 | Invisalign, Invisalign First - Comprehensive, Other |
| World Class Technology Corporation | $390.70 | 2019-2022 | |
| Stryker Corporation | $142.18 | 2023 | Na, Vsp System, Vsp Cranial |
| American Orthodontics Corporation | $82.91 | 2022-2025 | LP and Ifit Tubes, Empower-Metal, Radiance |
| Gc America INC. | $32.40 | 2019 | |
| Biolase, INC. | $28.58 | 2020 | |
| Philips North America LLC | $12.31 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Nowlin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.